Afya Ltd

Afya CFO sells 10,000 shares at $15.20, sparking investor concern over insider sell‑offs; yet solid fundamentals and growth plans may offset short‑term volatility.

Afya’s recent insider sales show a liquidity shift—VP and CFO sell shares amid a 52‑week low—yet the physician‑centric platform still offers upside potential for cautious investors.